A B S T R A C T
The most prevalent strain of Mycobacterium tuberculosis in Madrid, Spain (strain 5) was recovered from 45 cases between 1997 and 2004 and showed a highly homogeneous genetic composition. This strain was not exclusive to Spain, and its spoligotyping signature (ST20) was found in entries from different countries in the SITVIT1 database. Patients infected with strain 5 were more frequently positive for human immunodeficiency virus and autochthonous, and had been in prison more frequently, but strain 5 did not show increased infectivity in an in-vitro model of infection.
Keywords Epidemiology, infectivity, Mycobacterium tuberculosis, spoligotyping, ST20 In total, 1207 MTB isolates were analysed by IS6110 restriction fragment length polymorphism [6] , yielding 867 different genotypes, with 455 (37.7%) isolates grouped in 115 clusters; 51.3% of the clusters included two isolates, and only 9.6% of the clusters included more than six isolates. Nevertheless, some large clusters were detected, with the four largest clusters corresponding to strains 5 (45 cases), 2, 8 and 38 (20 cases each). Strain 5 was isolated from the highest number of cases (3.7% of the total) and was therefore selected for in-depth characterisation. This strain showed an eight-band restriction fragment length polymorphism pattern ( Fig. 1 ) and was isolated in all but one of the years of the study. Of 45 cases infected with strain 5, 37 were males, 18 were positive for human immunodeficiency virus, two were foreign-born, 12 were diagnosed while in prison, and ten were intravenous drug users.
Strain 5 was detected previously during 1993-1994, at which time it was predominant among three strains responsible for the highest number of cases in a prison population [7] . In the present study, strain 5 still persisted after 13 years, while the two other strains had declined in importance, suggesting that strain 5 is favoured over other strains.
Additional spoligotyping [8] and mycobacterial interspersed repetitive units variable number tandem repeats (MIRU-VNTR) analysis [9] revealed a highly robust and homogeneous genetic profile, with all but one of the patients infected by isolates sharing identical genotypes (ST20: 677777607760771, which is a feature of the LAMsuperfamily), and all isolates sharing identical MIRU-VNTR types (MIT25: 224226153321; Fig. 1 ). In one of the patients, MIRU-VNTR analysis detected a co-infection with two clonal variants, differing by one and three repeats in two loci, but indistinguishable by restriction fragment length polymorphism or spoligotyping (Fig. 1b) . This genotypic homogeneity also suggests that strain 5 is somehow favoured, which may ensure its genetic homogeneity, or that this strain was only introduced to Spain recently and has not yet diverged genetically. In contrast, isolates of the three other prevalent strains (strains 2, 8 and 38) frequently showed differences among their spoligotypes (data not shown).
Features linked to clustering in Madrid are an age of <35 years and intravenous drug use [4, 5, 7] . Compared with cases infected by other strains, Spanish birth, human immunodeficiency virus infection and prison stay were associated significantly with infection by strain 5 (p <0.05). Twelve cases infected with strain 5 were from the same district, but epidemiological links were found for only three pairs of brothers. Evidence of strain 5 infecting immigrants was detected, suggesting that immigrants could become infected after their arrival by strains that are prevalent in the host country.
In order to establish whether strain 5 was specific to Spain, the SITVIT1 database (http://www. pasteur-guadeloupe.fr/SITVIT) was searched for strains sharing the same spoligotype (ST20). Unlike the Madrid 1 and 2 strains [10] , the spoligotype signature of strain 5 was not specific to Spain, with 378 cases matching ST20 reported from 37 countries other than Spain. Of these, strain 5 was overrepresented in the database entries from Brazil (7%), Portugal (12%), Venezuela (6%), Haiti (6%) and Namibia (15%).
The infectivity of a representative of strain 5 was assayed in comparison with the virulent reference strain H37Rv, and with a representative 'orphan' strain (isolated from only one patient during the same study period), by measuring its intracellular growth in an in-vitro infection model using the human promonocytic cell line THP-1 activated with phorbol 12-myristate 13-acetate [11, 12] . Cell monolayers were infected in duplicate with 0.5-5 bacteria ⁄ cell, prepared from strains that had been passaged on fewer than four occasions after primary isolation. After incubation, the monolayers were washed thoroughly with phosphate-buffered saline to remove extracellular bacteria, and fresh medium was then added. To evaluate bacterial growth, the supernatants were aspirated and monolayers were lysed after 3 h (time 0) and 1, 4 and 7 days after infection. Serial dilutions of cellular lysates were plated on Middlebrook 7H11 plates and colonies were counted (Table 1) . The results showed that the growth ratio for strain 5 was superior to that obtained for the orphan strain at the three time-points analysed, indicating a replication advantage for strain 5. However, compared with the virulent reference strain, the growth rate for strain 5 was higher only at the 1-day time-point.
Epidemiological and bacteriological features leading to a high prevalence of specific strains have been observed in other settings. For example, in Manitoba, Canada, the prevalent 'type 1' strain seems to have epidemiological links with the native population that could favour its prevalence, although bacterial factors also seem to be involved [13, 14] . The present study showed that strain 5 could have higher infectivity compared with other less frequent clinical strains, but that it is not a highly infective clone. More refined genomic or transcriptomic-based approaches may identify specific bacterial features that give a theoretical advantage to this strain, but the in-vitro data currently available suggest that epidemiological factors are mainly responsible for the prevalence of this strain.
Identification of other prevalent strains could help in monitoring changes in the profile of circulating MTB strains, and also in monitoring the epidemiological features associated with ongoing transmission. A panel of marker strains would be extremely useful in countries such as Spain, where the rise in the number of tuberculosis cases in immigrants is currently causing a transformation in the epidemiology of tuberculosis.
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